CD79A and ovarian carcinoma: Tumor B cell-derived IgA binds to the polymeric immunoglobulin IgA receptors (pIgR) on ovarian cancer cells and reprograms myeloid cells against extracellular oncogenic drivers, such as EGFR and KRAS, which causes cell death.